The acquisition is expected to see the integration of technologies from two companies in product development and marketing to offer customer benefits through complementary product and service solutions.
GE Healthcare Life Sciences chief technology officer and vice president of BioTechnologies Nigel Darby said GE and Xcellerex together can help customers optimize every stage of their manufacturing process and has the potential to increase production flexibility and to deliver higher yields of finished product while reducing time to market.
"We believe that combining the skills of the two companies will bring great benefits for our customers in the industry," Darby said.